MX358504B - Lagrimas artificiales y usos terapeuticos. - Google Patents
Lagrimas artificiales y usos terapeuticos.Info
- Publication number
- MX358504B MX358504B MX2014012100A MX2014012100A MX358504B MX 358504 B MX358504 B MX 358504B MX 2014012100 A MX2014012100 A MX 2014012100A MX 2014012100 A MX2014012100 A MX 2014012100A MX 358504 B MX358504 B MX 358504B
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- artificial tears
- therapeutic uses
- dog
- cat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención provee composiciones oftálmicas, v.gr., lágrimas artificiales, adecuadas para tratar síndrome de ojo seco en un humano u otro mamífero que padece el mismo, v.gr., un perro o gato, que comprende una mezcla de aceite de ricino con otro aceite, v.gr., un aceite alimenticio, v.gr., aceite de oliva, aceite de ajonjolí, aceite de maíz, etc.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18433909P | 2009-06-05 | 2009-06-05 | |
PCT/US2010/037153 WO2010141648A2 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
MX358504B true MX358504B (es) | 2018-08-21 |
Family
ID=42312750
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014012100A MX358504B (es) | 2009-06-05 | 2010-06-03 | Lagrimas artificiales y usos terapeuticos. |
MX2011013007A MX2011013007A (es) | 2009-06-05 | 2010-06-03 | Lagrimas artificiales y usos terapeuticos. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011013007A MX2011013007A (es) | 2009-06-05 | 2010-06-03 | Lagrimas artificiales y usos terapeuticos. |
Country Status (24)
Country | Link |
---|---|
US (6) | US8496976B2 (es) |
EP (1) | EP2437762B1 (es) |
KR (1) | KR101778316B1 (es) |
CN (2) | CN102458430A (es) |
AU (1) | AU2010256652B2 (es) |
BR (1) | BRPI1011710B8 (es) |
CA (1) | CA2764802A1 (es) |
DK (1) | DK2437762T3 (es) |
ES (1) | ES2646338T3 (es) |
HK (1) | HK1214943A1 (es) |
HR (1) | HRP20171691T1 (es) |
HU (1) | HUE034213T2 (es) |
IL (1) | IL216800A (es) |
LT (1) | LT2437762T (es) |
MX (2) | MX358504B (es) |
MY (1) | MY172185A (es) |
NO (1) | NO2437762T3 (es) |
NZ (1) | NZ596932A (es) |
PL (1) | PL2437762T3 (es) |
PT (1) | PT2437762T (es) |
RU (1) | RU2589837C2 (es) |
SI (1) | SI2437762T1 (es) |
WO (1) | WO2010141648A2 (es) |
ZA (1) | ZA201108979B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
WO2010141648A2 (en) | 2009-06-05 | 2010-12-09 | Allergan, Inc. | Artificial tears and therapeutic uses |
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
IN2014CN04809A (es) * | 2011-12-07 | 2015-09-18 | Allergan Inc | |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
US10085960B2 (en) | 2012-03-30 | 2018-10-02 | Brien Holden Vision Institute | Methods and compositions for reducing ocular discomfort |
US9289494B2 (en) | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
US9394355B2 (en) | 2014-08-20 | 2016-07-19 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
EP3223794A1 (en) * | 2014-11-25 | 2017-10-04 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
WO2017066429A1 (en) | 2015-10-14 | 2017-04-20 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
JP2019519596A (ja) | 2016-04-08 | 2019-07-11 | コーネル・ユニバーシティーCornell University | シルク由来タンパク質を使用して創傷治癒を増進する方法 |
JOP20170147B1 (ar) * | 2016-07-07 | 2021-08-17 | Salvat Lab Sa | تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة |
KR102275012B1 (ko) | 2016-08-12 | 2021-07-07 | 실크 테크놀로지스 리미티드 | 염증 치료용 실크 유래 단백질 |
WO2018035469A1 (en) * | 2016-08-19 | 2018-02-22 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
KR20200037230A (ko) * | 2017-06-30 | 2020-04-08 | 제니비젼 인크. | 모발 성장용 제제 |
JP7311160B2 (ja) | 2017-08-18 | 2023-07-19 | アクリビスタ エルエルシー | ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物 |
CN112739337B (zh) | 2018-07-27 | 2024-05-24 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
AU2019311849B2 (en) | 2018-07-27 | 2023-06-08 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
CN112888450A (zh) | 2018-07-27 | 2021-06-01 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
KR20210009947A (ko) | 2019-07-18 | 2021-01-27 | 윤영선 | 산소가 도입된 점안제, 및 그 제조방법 |
EP3824877A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
EP3824895A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56104814A (en) * | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
DE3851152T2 (de) | 1987-09-03 | 1995-01-26 | Univ Georgia | Cyclosporin-augenmittel. |
FR2638089A1 (fr) * | 1988-10-26 | 1990-04-27 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
WO1997024129A1 (en) | 1995-12-27 | 1997-07-10 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical composition containing trehalose |
US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
GB0012597D0 (en) | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
US7027446B2 (en) | 2001-07-18 | 2006-04-11 | P-Cube Ltd. | Method and apparatus for set intersection rule matching |
JP4284491B2 (ja) | 2002-07-16 | 2009-06-24 | 豊和工業株式会社 | ピストン外形の加工データ生成装置 |
TWI335819B (en) * | 2002-12-24 | 2011-01-11 | Alcon Inc | Use of oculosurface selective glucocorticoid in the treatment of dry eye |
DK1599186T3 (da) * | 2003-02-24 | 2013-07-08 | Pharmaceutical Productions Inc | System til administration af transmukalt lægemiddel |
US20060251685A1 (en) * | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
CA2572344A1 (en) | 2004-07-01 | 2006-01-19 | Schepens Eye Research | Compositions and methods for treating eye disorders and conditions |
JPWO2006022291A1 (ja) * | 2004-08-27 | 2008-05-08 | 千寿製薬株式会社 | ドライアイ治療用点眼液 |
US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
CN100562340C (zh) * | 2005-06-17 | 2009-11-25 | 中国科学院上海药物研究所 | 一种微乳型人工泪液 |
US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
WO2008027341A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
BRPI0808410A2 (pt) * | 2007-02-28 | 2015-06-23 | Aciex Therapeutics Inc | Métodos e composições para normalizar secreções da glândula meibomiana |
CN101554369B (zh) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 |
UA36915U (uk) * | 2008-05-28 | 2008-11-10 | Львівський Національний Медичний Університет Ім. Данила Галицького | Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами |
IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
WO2010141648A2 (en) | 2009-06-05 | 2010-12-09 | Allergan, Inc. | Artificial tears and therapeutic uses |
-
2010
- 2010-06-03 WO PCT/US2010/037153 patent/WO2010141648A2/en active Application Filing
- 2010-06-03 CN CN2010800348429A patent/CN102458430A/zh active Pending
- 2010-06-03 DK DK10724631.6T patent/DK2437762T3/da active
- 2010-06-03 LT LTEP10724631.6T patent/LT2437762T/lt unknown
- 2010-06-03 NZ NZ596932A patent/NZ596932A/en unknown
- 2010-06-03 EP EP10724631.6A patent/EP2437762B1/en not_active Revoked
- 2010-06-03 ES ES10724631.6T patent/ES2646338T3/es active Active
- 2010-06-03 PT PT107246316T patent/PT2437762T/pt unknown
- 2010-06-03 NO NO10724631A patent/NO2437762T3/no unknown
- 2010-06-03 SI SI201031575T patent/SI2437762T1/en unknown
- 2010-06-03 RU RU2011151468/15A patent/RU2589837C2/ru active
- 2010-06-03 HU HUE10724631A patent/HUE034213T2/en unknown
- 2010-06-03 PL PL10724631T patent/PL2437762T3/pl unknown
- 2010-06-03 CA CA2764802A patent/CA2764802A1/en not_active Abandoned
- 2010-06-03 AU AU2010256652A patent/AU2010256652B2/en active Active
- 2010-06-03 KR KR1020127000233A patent/KR101778316B1/ko active IP Right Grant
- 2010-06-03 MX MX2014012100A patent/MX358504B/es unknown
- 2010-06-03 CN CN201510225116.XA patent/CN104906170A/zh active Pending
- 2010-06-03 BR BRPI1011710A patent/BRPI1011710B8/pt active IP Right Grant
- 2010-06-03 MX MX2011013007A patent/MX2011013007A/es active IP Right Grant
- 2010-06-03 MY MYPI2012000497A patent/MY172185A/en unknown
- 2010-06-03 US US13/376,374 patent/US8496976B2/en active Active
-
2011
- 2011-12-06 IL IL216800A patent/IL216800A/en active IP Right Grant
- 2011-12-07 ZA ZA2011/08979A patent/ZA201108979B/en unknown
-
2013
- 2013-06-28 US US13/931,281 patent/US8679554B2/en active Active
-
2014
- 2014-01-28 US US14/166,589 patent/US9821020B2/en active Active
-
2016
- 2016-03-14 HK HK16102876.7A patent/HK1214943A1/zh unknown
-
2017
- 2017-10-23 US US15/791,158 patent/US11045515B2/en active Active
- 2017-11-06 HR HRP20171691TT patent/HRP20171691T1/hr unknown
-
2021
- 2021-05-25 US US17/329,586 patent/US20220008496A1/en not_active Abandoned
-
2023
- 2023-08-03 US US18/364,692 patent/US20240108677A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY172185A (en) | Artificial tears and therapeutic uses | |
PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
MY169328A (en) | Compositions for the treatment of dry eye | |
MY173616A (en) | Compositions and methods for lowering triglycerides | |
WO2012064973A3 (en) | Heterocyclic compounds and uses thereof | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
CO6571886A2 (es) | Antagonistas de pcsk9 | |
WO2010083239A3 (en) | Therapeutic modulation of vaginal epithelium boundary lubrication | |
AU2012253759A8 (en) | Tricyclic sulfonamide compounds and methods of making and using same | |
EA201290498A1 (ru) | Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения | |
IN2012DN02469A (es) | ||
WO2011019822A3 (en) | Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products | |
MY171920A (en) | Prevention and treatment of ocular conditions | |
PL2262476T3 (pl) | Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
MX2011013060A (es) | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. | |
WO2009089635A9 (en) | Treating neurodegenerative diseases with progranulin (pgrn) | |
IN2012DN00624A (es) | ||
MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
UA108878C2 (ru) | Ингибиторы протеинтирозинкиназной активности | |
UY33153A (es) | Formulación tópica oftálmica de péptidos | |
WO2011011706A3 (en) | Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |